Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: A case report and literature review

Journal of Infection in Developing Countries

Volumn 7, Issue 5, 2013, Pages 424-431

  Elaldi, Nazif ^a   Gozel, Mustafa G ^a   Kolayli, Fetiye ^b   Engin, Aynur ^a   Celik, Cem ^a   Bakici, Mustafa Z ^a   Vahaboglu, Haluk ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

CTX M 15; Escherichia coli; Meningitis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APHASIA; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; BRAIN VENTRICLE DILATATION; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COMMUNICABLE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DNA SEQUENCE; DRUG WITHDRAWAL; EARDRUM PERFORATION; ESCHERICHIA COLI; FECES CULTURE; GRAM STAINING; HUMAN; HYPEREMIA; ISOELECTRIC FOCUSING; LEUKOCYTE; LIQUORRHEA; LUMBAR PUNCTURE; MALE; MASTOIDECTOMY; MINIMUM INHIBITORY CONCENTRATION; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; OTORRHEA; OTOSCOPY; POLYMERASE CHAIN REACTION; PTOSIS; REVIEW; SUPPURATION; THROAT CULTURE;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; BLOOD; CEREBROSPINAL FLUID; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; FECES; HUMANS; MALE; MENINGITIS, ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA WITH EFFUSION; TREATMENT OUTCOME;

EID: 84877893579     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2820     Document Type: Review

References (22)

1. Boyer-Mariotte S, Duboc P, Bonacorsi S, Lemeland JF, Bingen E, Pinquier D (2008) CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J Antimicrob Chemother 62: 1472-1474.
2. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
3. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39: 1267-1284.
4. Rossolini GM, D'Andrea MM, Mugnaioli C (2008) The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14 Suppl 1: 33-41.
5. Hawkey PM and Jones AM (2009) The changing epidemiology of resistance. J Antimicrob Chemother 64 suppl 1: i3-i10.
6. Gonullu N, Aktas Z, Kayacan CB, Salcioglu M, Carattoli A, Yong DE, Walsh TR (2008) Dissemination of CTX-M-15 b-lactamase genes carried on Inc FI and II plasmids among clinical isolates of Escherichia coli in a University Hospital in Istanbul, Turkey. J Clin Microbiol 46: 1110-1112.
7. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP (2008) Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 62: 284-288.
8. Azap OK, Arslan H, Serefhanoǧlu K, Colakoǧlu S, Erdoǧan H, Timurkaynak F, Senger SS (2010) Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect 16: 147-151.
9. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, Vahaboglu H (2004) PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 10: BR180-184.
10. Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboǧlu H, Akata F (2010) CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey. J Microbiol Immunol Infect 43: 163-167.
11. Ramdani-Bouguessa N, Mendonc N, Leitao, Ferreira E, Tazir M, Caniça M (2006) CTX-M-3 and CTX-M-15 extendedspectrum b-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J Clin Microbiol 44: 4584-4586.
12. Moissenet D, Salauze B, Clermont O, Bingen E, Arlet G, Denamur E, Mérens A, Mitanchez D, Vu-Thien H (2010) Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain. J Clin Microbiol 48: 2459-2463.
13. Andrade LN, Minarini LA, Pitondo-Silva A, Clímaco EC, Palazzo IC, Medeiros MI, Darini AL (2010) Determinants of beta-lactam resistance in meningitis-causing Enterobacteriaceae in Brazil. Can J Microbiol 56: 399-407.
14. Nakwan N, Nakwan N, Wannaro J, Dissaneevate P, Kritsaneepaiboon S, Chokephaibulkit K (2011) Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli. Southeast Asian J Trop Med Public Health 42: 148-151.
15. Weyrich P, Ettahar N, Legout L, Meybeck A, Leroy O, Senneville E (2012) First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms. Ann Clin Microbiol Antimicrob 11:4.
16. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A (2008) Faecal carriage of extendedspectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 62: 1142-1149.
17. Gundes S, Arisoy AE, Kolayli F, Karaali E, Turker G, Sanic A, Arisoy ES, Vahaboglu H (2005) An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization. New Microbiol 28: 231-236.
18. Taziarova M, Holeckova K, Lesnakova A, Sladeckova V, Bartkovjak M, Seckova S, Bukovinova P, Hvizdak F, Svabova V, Findova L, Kisac P, Beno P, Bauer F, Bauer M, Karvaj M, Rudinsky B, Sabo I, Bielova M, Luzica R, Wiczmandyova O, Huttova M, Ondrusova A (2007) Gramnegative bacillary community acquired meningitis is not a rare entity in last two decades. Neuro Endocrinol Lett 28 Suppl 3: 18-19.
19. van de Beek D, Drake JM, Tunkel AR (2010) Nosocomial bacterial meningitis. N Engl J Med 362: 146-154.
20. Schwaber MJ and Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum betalactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60: 913-920.
21. Melzer M and Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum betalactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 55: 254-259.
22. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328: 21-28.